Nevertheless, the downstream pathway of EP2 needs to be examined in more detail since it has the potential to become a target for renal fibrosis treatment and can also inspire new ideas for clinical treatment of renal fibrosis. The gene discussed is PTGER2; the disease is renal fibrosis.